KR890010562A - Active RNase L as a Marker of Virus Infection - Google Patents
Active RNase L as a Marker of Virus Infection Download PDFInfo
- Publication number
- KR890010562A KR890010562A KR1019880002189A KR880002189A KR890010562A KR 890010562 A KR890010562 A KR 890010562A KR 1019880002189 A KR1019880002189 A KR 1019880002189A KR 880002189 A KR880002189 A KR 880002189A KR 890010562 A KR890010562 A KR 890010562A
- Authority
- KR
- South Korea
- Prior art keywords
- hiv
- rnase
- inhibitor
- derna
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
내용 없음No content
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
제1도는 리보소말 RNA 분해분석에 의해 결정된 것으로서 LAS, ARC 또는 AIDS를 앓고 있는 인간의 PBMC추출물로 부터 추출된 2-5A로 RN 아제 L을 활성화시킴으로서 나타난 폴리아크릴아미드 겔의 전기영동 플레이트 포토그래프이며,1 is an electrophoretic plate photograph of a polyacrylamide gel, as determined by ribosomal RNA digestion assay, shown by activating RNase L with 2-5A extracted from human PBMC extracts suffering from LAS, ARC or AIDS. ,
제2도는 리보소말 RNA 분해분석에 의해 결정된 것으로서 RBMC 추출물에서 RN 아제 L레벨을 활성화시켜 나타난 겔 전기영동 플레이트 프로그래프이다.FIG. 2 is a gel electrophoretic plate program shown by activating RNase L levels in RBMC extracts as determined by ribosomal RNA digestion assays.
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13697887A | 1987-12-23 | 1987-12-23 | |
US136978 | 2002-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890010562A true KR890010562A (en) | 1989-08-09 |
Family
ID=22475294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880002189A KR890010562A (en) | 1987-12-23 | 1988-03-03 | Active RNase L as a Marker of Virus Infection |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0325018A3 (en) |
JP (1) | JP2690493B2 (en) |
KR (1) | KR890010562A (en) |
CN (1) | CN1043569A (en) |
AU (2) | AU1256488A (en) |
CA (1) | CA1337277C (en) |
DK (1) | DK112988A (en) |
FI (1) | FI880960A (en) |
HU (1) | HU205460B (en) |
IL (1) | IL85577A0 (en) |
NO (1) | NO880935L (en) |
OA (1) | OA08815A (en) |
PH (1) | PH25365A (en) |
PT (1) | PT86880B (en) |
RU (1) | RU1836101C (en) |
SU (1) | SU1687035A3 (en) |
ZA (1) | ZA881470B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5278042A (en) * | 1989-02-06 | 1994-01-11 | The United States Of America As Represented By The Department Of Health & Human Services | Method for detecting inhibitors of tat protein |
FR2725214A1 (en) * | 1994-09-30 | 1996-04-05 | Inst Nat Sante Rech Med | NOVEL COMPOUNDS FOR PREPARING ANTI-INFECTIOUS AGENTS |
US5985565A (en) | 1996-10-09 | 1999-11-16 | Temple University-Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
CZ295108B6 (en) | 1998-03-20 | 2005-05-18 | Benitec Australia Ltd | Synthetic gene comprising dispersed or foreign deoxyribonucleic molecule and a gene construct containing such a synthetic gene |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
AU776150B2 (en) | 1999-01-28 | 2004-08-26 | Medical College Of Georgia Research Institute, Inc. | Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA |
US6207366B1 (en) | 1999-04-14 | 2001-03-27 | Temple University- Of The Commonwealth System Of Higher Education | Chronic fatigue syndrome diagnosis |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
EP1229134A3 (en) | 2001-01-31 | 2004-01-28 | Nucleonics, Inc | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
CN112088903A (en) * | 2020-09-28 | 2020-12-18 | 武汉愔紫生物科技有限公司 | Application of macromolecular protein in antibacterial and antiviral disinfectant |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2505845A1 (en) * | 1981-05-13 | 1982-11-19 | Choay Sa | Substrate system for oligo-adenylate synthetase assay - used to diagnose infection and measure interferon concn. |
DE3380200D1 (en) * | 1982-09-16 | 1989-08-24 | William Alvin Carter | Anti-proliferative action of dsnras on tumor cells |
CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
-
1988
- 1988-02-24 PH PH36551A patent/PH25365A/en unknown
- 1988-02-29 CA CA000560051A patent/CA1337277C/en not_active Expired - Fee Related
- 1988-02-29 IL IL85577A patent/IL85577A0/en not_active IP Right Cessation
- 1988-03-02 ZA ZA881470A patent/ZA881470B/en unknown
- 1988-03-02 JP JP63047657A patent/JP2690493B2/en not_active Expired - Fee Related
- 1988-03-02 DK DK112988A patent/DK112988A/en not_active Application Discontinuation
- 1988-03-02 PT PT86880A patent/PT86880B/en not_active IP Right Cessation
- 1988-03-02 EP EP88301820A patent/EP0325018A3/en not_active Withdrawn
- 1988-03-02 FI FI880960A patent/FI880960A/en not_active Application Discontinuation
- 1988-03-02 NO NO88880935A patent/NO880935L/en unknown
- 1988-03-02 AU AU12564/88A patent/AU1256488A/en not_active Abandoned
- 1988-03-02 HU HU881015A patent/HU205460B/en not_active IP Right Cessation
- 1988-03-03 CN CN88101696A patent/CN1043569A/en active Pending
- 1988-03-03 KR KR1019880002189A patent/KR890010562A/en not_active Application Discontinuation
- 1988-03-03 OA OA59295A patent/OA08815A/en unknown
- 1988-03-03 SU SU884355467A patent/SU1687035A3/en active
- 1988-10-26 RU SU884356721A patent/RU1836101C/en active
-
1992
- 1992-05-12 AU AU16187/92A patent/AU660973B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0325018A2 (en) | 1989-07-26 |
RU1836101C (en) | 1993-08-23 |
CN1043569A (en) | 1990-07-04 |
CA1337277C (en) | 1995-10-10 |
DK112988D0 (en) | 1988-03-02 |
SU1687035A3 (en) | 1991-10-23 |
PH25365A (en) | 1991-05-13 |
AU1256488A (en) | 1989-06-29 |
EP0325018A3 (en) | 1990-01-17 |
FI880960A (en) | 1989-06-24 |
IL85577A0 (en) | 1988-08-31 |
NO880935D0 (en) | 1988-03-02 |
AU660973B2 (en) | 1995-07-13 |
NO880935L (en) | 1989-06-26 |
PT86880A (en) | 1988-04-01 |
DK112988A (en) | 1989-06-24 |
OA08815A (en) | 1989-03-31 |
FI880960A0 (en) | 1988-03-02 |
PT86880B (en) | 1993-01-29 |
JP2690493B2 (en) | 1997-12-10 |
ZA881470B (en) | 1988-11-18 |
HUT47745A (en) | 1989-03-28 |
JPH01171500A (en) | 1989-07-06 |
HU205460B (en) | 1992-04-28 |
AU1618792A (en) | 1992-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bonacini et al. | Patients co‐infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA | |
Ratzan | Viral meningitis | |
Faraoni et al. | Evaluation of a rapid antigen and antibody combination test in acute HIV infection | |
KR890010562A (en) | Active RNase L as a Marker of Virus Infection | |
Pasquier et al. | Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV‐1) and HCV | |
Mendoza et al. | COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing | |
Fanning et al. | Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective study | |
Healey et al. | Acute hepatitis C infection after sexual exposure. | |
BR9804648A (en) | Monitoring of patient compliance with treatment and bioavailability of drugs by deproteinization of body fluids. | |
Fabris et al. | High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners | |
EP1563308A4 (en) | Methods and kits for diagnosing tumorigenicity | |
KR880011593A (en) | Active RNase L as Marker of Virus Infection | |
CN104846116A (en) | PCR primer groups and probe used for detecting human immunodeficiency virus type I, kit containing PCR primer groups and probe, and detection method | |
Keiserman et al. | Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection | |
Sacks | Improving the management of genital herpes | |
Jehuda-Cohen | The HIV seronegative Window period: diagnostic challenges and solutions | |
WO2014175827A1 (en) | Diagnostic kit for rapidly diagnosing a dengue virus, a method of preparing the diagnostic kit and a method of rapidly diagnosing a dengue virus using the diagnostic kit | |
SULKIN et al. | The Frei Test for Lymphogranuloma Venereum: Experiences with a New Antigen (Lygranum) Prepared from Infected Yolk Sac of Developing Chick Embryo | |
Psomas | Of HIV and men | |
MacDougall | Redefining the role of HIV viral load monitoring | |
Utu-Baku | Effect of therapeutic and toxic doses of ivermectin (Mectizan) on total serum proteins and hepatic enzymes of wistar albino rats | |
Trivedi | Newly diagnosed hepatitis C: Lack of symptoms doesn't mean lack of progression | |
Toyohama et al. | Kaposi's sarcoma in a human immunodeficiency virus-negative patient treated with corticosteroid for idiopathic thrombocytopenic purpura | |
Ercoli | Studies on the therapeutic resistance of cutaneous leishmania infections | |
Leggat et al. | Could it be lymphatic filariasis? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |